DiVita Michael, Visveswaran Gautam K, Makam Kasaiah, Naji Peyman, Cohen Marc, Kapoor Saurabh, Saunders Craig R, Zucker Mark J
Department of Cardiology, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA.
Department of Heart Failure and Transplant, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, USA.
Eur Heart J Case Rep. 2020 Jan 6;4(1):1-6. doi: 10.1093/ehjcr/ytz234. eCollection 2020 Feb.
Acute severe mitral regurgitation (MR) associated with cardiogenic shock is a life-threatening emergency. Traditional teaching has focused on the need for emergent coronary angiography and/or intra-aortic balloon counterpulsation in preparation for emergent open-heart surgery for repair/replacement. Unfortunately, emergent open-heart surgery in patients with acute MR complicated by cardiogenic shock is associated with 25-46% perioperative mortality. New devices have provided additional options for stabilization prior to emergent surgery which facilitate improved outcomes.
We present two cases of acute severe MR resulting in cardiogenic shock and profound hypoxaemia. TandemHeart mechanical circulatory support with an oxygenator spliced into the circuit, akin to veno-arterial extracorporeal membrane oxygenation (ECMO), facilitated haemodynamic stabilization and decongestion of the lungs facilitating successful bridge to mitral valve surgery. Successful discharge to home was achieved in both patients with good neurological outcomes and sustained long-term functional recovery at 18 and 14 months, respectively.
Selective use of the TandemHeart, with or without ECMO, facilitates management of the critically ill cardiogenic shock patient with acute severe MR.
与心源性休克相关的急性重度二尖瓣反流(MR)是一种危及生命的紧急情况。传统教学重点在于,为急诊心脏直视手术进行修复/置换做准备时,需要进行急诊冠状动脉造影和/或主动脉内球囊反搏。不幸的是,急性MR合并心源性休克患者进行急诊心脏直视手术的围手术期死亡率为25%-46%。新设备为急诊手术前的稳定治疗提供了更多选择,有助于改善治疗结果。
我们报告两例急性重度MR导致心源性休克和严重低氧血症的病例。将带有氧合器的TandemHeart机械循环支持装置接入回路,类似于静脉-动脉体外膜肺氧合(ECMO),有助于血流动力学稳定和肺部消肿,为二尖瓣手术成功搭桥。两名患者均顺利出院,神经功能良好,分别在18个月和14个月时实现了长期功能持续恢复。
选择性使用TandemHeart,无论是否联合ECMO,都有助于治疗患有急性重度MR的危重心源性休克患者。